For those desiring to outshine the market, the strategic selection of individual stocks is paramount. Well-chosen stocks have the potential to substantially boost your wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
After finishing at $10.94 in the prior trading day, Skye Bioscience Inc (NASDAQ: SKYE) closed at $9.98, down -8.78%. In other words, the price has decreased by -$8.78 from its previous closing price. On the day, 1.27 million shares were traded. SKYE stock price reached its highest trading level at $10.06 during the session, while it also had its lowest trading level at $8.475.
Ratios:
Our goal is to gain a better understanding of SKYE by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 5.99 and its Current Ratio is at 5.99. In the meantime, Its Debt-to-Equity ratio is 0.06 whereas as Long-Term Debt/Eq ratio is at 0.00.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Cantor Fitzgerald on May 23, 2024, initiated with a Overweight rating and assigned the stock a target price of $21.
On April 12, 2024, Oppenheimer started tracking the stock assigning a Outperform rating and target price of $25.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, SKYE now has a Market Capitalization of 280117632 and an Enterprise Value of 201487440.
Stock Price History:
Over the past 52 weeks, SKYE has reached a high of $19.41, while it has fallen to a 52-week low of $1.44. The 50-Day Moving Average of the stock is -21.27%, while the 200-Day Moving Average is calculated to be 49.83%.
Shares Statistics:
The stock has traded on average 48.41K shares per day over the past 3-months and 182730 shares per day over the last 10 days, according to various share statistics. A total of 28.07M shares are outstanding, with a floating share count of 12.58M. Insiders hold about 55.18% of the company’s shares, while institutions hold 9.28% stake in the company. Shares short for SKYE as of 1715731200 were 232398 with a Short Ratio of 4.80, compared to 1713139200 on 46740. Therefore, it implies a Short% of Shares Outstanding of 232398 and a Short% of Float of 1.3200001.
Earnings Estimates
The dynamic stock of Skye Bioscience Inc (SKYE) is currently being evaluated by a team of 3 analysts, each contributing to its current rating.On average, analysts expect EPS of -$0.22 for the current quarter, with a high estimate of -$0.14 and a low estimate of -$0.27, while EPS last year was -$0.63. The consensus estimate for the next quarter is -$0.26, with high estimates of -$0.16 and low estimates of -$0.34.
Analysts are recommending an EPS of between -$0.65 and -$1.58 for the fiscal current year, implying an average EPS of -$1.11. EPS for the following year is -$1.4, with 3.0 analysts recommending between -$0.92 and -$1.8.
